Sub Heading

Clinical Trials Details

A Study to Assess Adverse Events and How Intravenously Infused Telisotuzumab Vedotin Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

IRB Protocol Number
AbbVie M25-274

Clinical Trial Categories

  • Lung Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: Men and women 18+ years old, with locally advanced or metastatic non-squamous cell NSCLC with c-Met overexpression, who have received no more than one line of prior chemotherapy in the locally advanced or metastatic setting.

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.